These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 34197905

  • 21. Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeys.
    Zamarripa CA, Huskinson SL, Townsend EA, Prisinzano TE, Blough BE, Rowlett JK, Freeman KB.
    Psychopharmacology (Berl); 2024 Feb; 241(2):305-314. PubMed ID: 37870564
    [Abstract] [Full Text] [Related]

  • 22. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
    Ko MC, Husbands SM.
    J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
    [Abstract] [Full Text] [Related]

  • 23. Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice.
    Negus SS, St Onge CM, Lee YK, Li M, Rice KC, Zhang Y.
    Molecules; 2024 Jul 16; 29(14):. PubMed ID: 39064909
    [Abstract] [Full Text] [Related]

  • 24. Kappa-opioid receptor stimulation in the nucleus accumbens shell and ethanol drinking: Differential effects by rostro-caudal location and level of drinking.
    Pirino BE, Hawks A, Carpenter BA, Candelas PG, Gargiulo AT, Curtis GR, Karkhanis AN, Barson JR.
    Neuropsychopharmacology; 2024 Sep 16; 49(10):1550-1558. PubMed ID: 38528134
    [Abstract] [Full Text] [Related]

  • 25. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
    Abraham AD, Fontaine HM, Song AJ, Andrews MM, Baird MA, Kieffer BL, Land BB, Chavkin C.
    Neuropsychopharmacology; 2018 Jan 16; 43(2):362-372. PubMed ID: 28649993
    [Abstract] [Full Text] [Related]

  • 26. Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
    Zamarripa CA, Naylor JE, Huskinson SL, Townsend EA, Prisinzano TE, Freeman KB.
    Psychopharmacology (Berl); 2020 May 16; 237(5):1471-1480. PubMed ID: 32006048
    [Abstract] [Full Text] [Related]

  • 27. Essential structure of the κ opioid receptor agonist nalfurafine for binding to the κ receptor.
    Nagase H, Fujii H.
    Curr Pharm Des; 2013 May 16; 19(42):7400-14. PubMed ID: 23448474
    [Abstract] [Full Text] [Related]

  • 28. Effects of kappa opioid receptor agonists on fentanyl vs. food choice in male and female rats: contingent vs. non-contingent administration.
    Townsend EA.
    Psychopharmacology (Berl); 2021 Apr 16; 238(4):1017-1028. PubMed ID: 33404739
    [Abstract] [Full Text] [Related]

  • 29. Discovery of attenuation effect of orexin 1 receptor to aversion of nalfurafine: Synthesis and evaluation of D-nor-nalfurafine derivatives and analyses of the three active conformations of nalfurafine.
    Nagumo Y, Katoh K, Iio K, Saitoh T, Kutsumura N, Yamamoto N, Ishikawa Y, Irukayama-Tomobe Y, Ogawa Y, Baba T, Tanimura R, Yanagisawa M, Nagase H.
    Bioorg Med Chem Lett; 2020 Sep 01; 30(17):127360. PubMed ID: 32738987
    [Abstract] [Full Text] [Related]

  • 30. [Pharmacological effects of nalfurafine hydrochloride, a kappa-opioid receptor agonist].
    Nakao K, Hasebe K, Yoshikawa S, Ikeda K, Hirakata M, Miyamoto Y, Mochizuki H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Nov 01; 30(5-6):185-91. PubMed ID: 21226314
    [Abstract] [Full Text] [Related]

  • 31. Kappa-opioid receptor antagonism in the nucleus accumbens shell distinguishes escalated alcohol consumption and negative affective-like behavior from physiological withdrawal in alcohol-dependence.
    Lepreux G, Henricks AM, Wei G, Go BS, Erikson CM, Abella RM, Pham A, Walker BM.
    Pharmacol Biochem Behav; 2024 Oct 01; 243():173840. PubMed ID: 39096973
    [Abstract] [Full Text] [Related]

  • 32. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
    Nakajima R, Yamamoto N, Hirayama S, Iwai T, Saitoh A, Nagumo Y, Fujii H, Nagase H.
    Bioorg Med Chem; 2015 Oct 01; 23(19):6271-9. PubMed ID: 26346669
    [Abstract] [Full Text] [Related]

  • 33. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
    Gross JD, Kaski SW, Schmidt KT, Cogan ES, Boyt KM, Wix K, Schroer AB, McElligott ZA, Siderovski DP, Setola V.
    Neuropsychopharmacology; 2019 Sep 01; 44(10):1728-1741. PubMed ID: 31141817
    [Abstract] [Full Text] [Related]

  • 34. Molecular mechanism of biased signaling at the kappa opioid receptor.
    El Daibani A, Paggi JM, Kim K, Laloudakis YD, Popov P, Bernhard SM, Krumm BE, Olsen RHJ, Diberto J, Carroll FI, Katritch V, Wünsch B, Dror RO, Che T.
    Nat Commun; 2023 Mar 11; 14(1):1338. PubMed ID: 36906681
    [Abstract] [Full Text] [Related]

  • 35. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P, Shimonova L, Khaimov A, Borukhova Y, Ilyayeva E, Ranaldi R, Bodnar RJ.
    Brain Res; 2012 Mar 14; 1443():34-51. PubMed ID: 22305145
    [Abstract] [Full Text] [Related]

  • 36. Early-Life Social Isolation Stress Increases Kappa Opioid Receptor Responsiveness and Downregulates the Dopamine System.
    Karkhanis AN, Rose JH, Weiner JL, Jones SR.
    Neuropsychopharmacology; 2016 Aug 14; 41(9):2263-74. PubMed ID: 26860203
    [Abstract] [Full Text] [Related]

  • 37. Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Tranfer.
    Barnett ME, Knapp BI, Bidlack JM.
    Mol Pharmacol; 2020 Oct 14; 98(4):462-474. PubMed ID: 32958572
    [Abstract] [Full Text] [Related]

  • 38. In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
    Nakao K, Togashi Y, Honda T, Momen S, Umeuchi H, Sakakibara S, Tanaka T, Okano K, Mochizuki H.
    Eur J Pharmacol; 2012 Nov 15; 695(1-3):57-61. PubMed ID: 22981641
    [Abstract] [Full Text] [Related]

  • 39. Accumbal μ-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats.
    Uhari-Väänänen J, Raasmaja A, Bäckström P, Oinio V, Airavaara M, Piepponen P, Kiianmaa K.
    Alcohol Clin Exp Res; 2016 Oct 15; 40(10):2114-2123. PubMed ID: 27508965
    [Abstract] [Full Text] [Related]

  • 40. Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys.
    Nakao K, Hirakata M, Miyamoto Y, Kainoh M, Wakasa Y, Yanagita T.
    J Pharmacol Sci; 2016 Jan 15; 130(1):8-14. PubMed ID: 26786553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.